SOX11 and ovarian serous adenocarcinoma: Given the small patient number, our findings undoubtedly represent an interesting observation concerning the role of SOX11 as a potential biomarker for metastatic serous ovarian cancer but still need to be studied in larger study populations in order to be further verified and avoid statistical errors due to study sample size.